Drugmaker, nonprofit unite on Alzheimer's disease targets

12/26/2011 | American City Business Journals

Bristol-Myers Squibb has entered into a research partnership with Gladstone Institutes to find and validate Alzheimer's disease targets. Gladstone will receive funding from Bristol to identify targets that affect Tau protein dysfunction.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID